Whole brain radiotherapy for the treatment of multiple brain metastases (Q24245002)

Adaptive radiation therapy

Europe PubMed Central

title

Whole brain radiotherapy for the treatment of multiple brain metastases (English)

0 references

main subject

brain

0 references

0 references

1 reference

5

Eileen Rakovitch

E

Rakovitch

1 reference

29 October 2023

4

Edward Chow

E

Chow

1 reference

29 October 2023

May N Tsao

1

M N

Tsao

1 reference

29 October 2023

Nancy Lloyd

series ordinal

2

author given names

N

author last names

Lloyd

1 reference

29 October 2023

Rebecca KS Wong

series ordinal

3

author given names

R

author last names

Wong

1 reference

29 October 2023

Normand Laperriere

series ordinal

6

author given names

N

author last names

Laperriere

1 reference

29 October 2023

language of work or name

1 reference

19 July 2006

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Whole brain irradiation for metastases from lung carcinoma. A clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

The management of metastases to the brain by irradiation and corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Final results of the Royal College of Radiologists' trial comparing two different radiotherapy schedules in the treatment of cerebral metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Supportive care for patients with gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Roentgen-ray therapy of cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Incorporating variations in the quality of individual randomized trials into meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Epidemiology of brain tumors: the national survey of intracranial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

Radiation therapy for brain metastases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

The combined use of radiation therapy and lonidamine in the treatment of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

Radiation therapy of cerebral metastases: a randomized prospective clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021

Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003869.PUB2

7 January 2021